best Nephrologist Dr Gopaluni Seerapani

Dr Gopaluni Seerapani Share Profile Citizens Hospitals

Nephrologist & Transplant Physician

Citizens Specialty Hospital, Nallagandla, Hyderabad.

Qualifications

MBBS, MRCP, CCT (UK), PhD (University of Cambridge)

Experience

15 Years

Available Timings

Monday - Saturday: 11 AM - 3 PM

Dr Gopaluni Seerapani

About:

Dr Gopaluni Seerapani is one of the top Nephrologists in India. He has over 15 years of experience as a Nephrologist in internationally renowned centres in the UK. He is working as a Consultant Nephrologist & Transplant Physician, a Specialist in Autoimmune Disease & Immuno – Nephrology at the Citizens Specialty Hospital, Hyderabad. He worked in three excellent transplant and renal centres (Leeds, Oxford and Cambridge) where he learnt the art of being a comprehensive renal physician. He is proficient in assessing patients’ suitability for renal transplantation, their peri-operative management, managing their immunosuppression and dealing with graft dysfunction. PhD from Cambridge, in auto-immune diseases, gave him the necessary immunological background required to be a successful transplant physician. He has a special interest in the diagnosis and management of patients with glomerulonephritis and autoimmune diseases. He is adept in dealing with various clinical aspects of chronic haemodialysis and peritoneal dialysis patients.

Qualifications:
  • MBBS – Dr. NTR University of Health Sciences, Andhra Pradesh (2003)
  • MRCP – Royal Colleges of Physicians, London, United Kingdom (2008)
  • MRCP (Nephrology) – The Federation of Royal College of Physicians, United Kingdom (2013)
  • CCT – General Internal Medicine Specialist Training – Oxford (2014)
  • CCT – Nephrology Specialist Training – Oxford (2014)
  • PhD (Autoimmune diseases) – University of Cambridge (2021)
Areas of Expertise:
  • He has enormous experience in all aspects of renal transplantation including complex ABO-incompatible and HLA-incompatible kidney transplantation
  • His immunology background puts him in a good stead to deal with some of the most complex disorders such as lupus, vasculitis including small, medium and large vessel vasculitides and other multi-system disorders
  • He excels in counselling the patients and providing them with adequate information to make informed decisions
  • He has vast experience in general medicine and deals with some of the most complex non-renal diseases too
  • His procedural skills include tunneled permanent dialysis lines, peritoneal dialysis catheter insertion, ultrasound guided native and transplant kidney biopsies
Awards & Achievements:
  • Dr APJ Abdul Kalam Health & Medical Excellence Award – 2024
  • Granted £2 Million to conduct a clinical trial called BIOVAS by NIHR - 2019
  • Granted £45,000 by Vasculitis UK Organization to conduct a clinical study - 2017
  • £250,000 Experimental Medicine Training Initiative fellowship - 2016
  • Received Distinction in the Anatomy / ENT/ Ophthalmology in the University Examination
Languages Known:
  • Telugu
  • English
  • Hindi
Publications:
  • Wagner J, Harrison E. M, Martinez M, Pero D, Blane B, Mayer G, Leierer J, Gopaluni S, Holmes M A, Parkhill J, Peacock S J, Jayne D R, Kronbichler A (2019). The composition and functional protein subsystems of the human nasal microbiome in granulomatosis with polyangiitis: a pilot study. Microbiome (2019) 7:137
  • https://doi.org/10.1186/s40168-019-0753-z
  • Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis. McClure ME, Wason J, Gopaluni S, Tieu J, Smith RM, Jayne DR, Jones RB. J Clin Rheumatol. 2019 Mar 20. doi: 10.1097/RHU.0000000000001030
  • A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis. Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J, Hamour S, Burns A, Griffith M, Galliford J, Levy JB, Cairns TD, Gopaluni S, Jones RB, Jayne D, Little MA, Pusey CD, Salama AD. Rheumatology (Oxford). 2019 Feb 1;58(2):260-268. doi: 10.1093/rheumatology/key288.
  • Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Gopaluni S, Flossmann O, Little MA, O’Hara P, Bekker P, Jayne D; European Vasculitis Society. Arthritis Rheumatol. 2019 May;71(5):784-791. doi: 10.1002/art.40776. Epub 2019 Mar 28.
  • B cell therapy in ANCA-associated vasculitis: current and emerging treatment options. McClure M, Gopaluni S, Jayne D, Jones R. Nat Rev Rheumatol. 2018 Oct;14(10):580- 591. doi: 10.1038/s41584-018-0065-x. Epub 2018 Aug 14. Review.
  • A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts. Karadag O, Erden A, Bilginer Y, Gopaluni S, Sari A, Armagan B, Ertenli I, Ozen S, Jayne D. Rheumatol Int. 2018 Oct;38(10):1833-1840. doi: 10.1007/s00296-018-4122-1. Epub 2018 Aug 11.
  • Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis. Kronbichler A, Kerschbaum J, Gopaluni S, Tieu J, Alberici F, Jones RB, Smith RM, Jayne DRW. Ann Rheum Dis. 2018 Oct;77(10):1440-1447. doi: 10.1136/annrheumdis2017-212861. Epub 2018 Jun 27.
  • McAdoo, S. P., Medjeral-Thomas, N., Gopaluni, S., Tanna, A., Mansfield, N., Galliford, J., Griffith, M., et al. (2018). Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis.. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association, 2018, 33 (5), 899.
  • https://doi.org/10.1093/ndt/gfy075
  • Gopaluni, S., Smith, R. M., Lewin, M., McAlear, C. A., Mynard, K., Jones, R. B., Jayne, D. R. W. (2017). Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial. Trials, 18(1), 112.
  • http://doi.org/10.1186/s13063-017-1857-z
  • Gopaluni, S., Sherif, M., & Ahmadouk, N. A. 2016. Cochrane systematic review: Interventions for chronic kidney disease-associated restless legs syndrome. Cochrane Database of Systematic Reviews. doi: 10.1002/ 14651858. CD010690.pub2
  • Gopaluni, S., & Jayne, D. (2016). Clinical Trials in Vasculitis. Current Treatment Options in Rheumatology, 2(2), 161–177. doi:10.1007/s40674-016-0045-8
  • Gopaluni, S. and Jayne, D. 2015. Immune Vasculitis. eLS. 1–8. DOI: 10.1002/9780470015902.a0002150.pub3
  • Hindocha, S., Gopaluni, S., Collins, G. P., & Shenbagaraman, P. (2015). Focal segmental glomerulosclerosis in a patient with mantle cell lymphoma. BMJ Case Reports, 2015. doi:10.1136/bcr-2015-211765
  • Gopaluni, S., Gibson, M., & Mohteshamzadeh, M. (2014). An unusual case of familial cystic kidney disease. Clinical Kidney Journal, 7(5), 484–485. doi:10.1093/ckj/sfu075
  • Gopaluni, S., Sherif, M., & Ahmadouk, N. A. (2013). Protocol- Interventions for chronic kidney disease-associated restless legs syndrome. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD010690.
  • Ball MJ, Gopaluni S, Mathavakkannan S, Brian M, and Farrington K. An immunocompromised dialysis patient with skin and bone lesions. NDT Plus 2010 0: sfq010v1-sfq010; doi:10.1093/ndtplus/sfq010
  • S Gopaluni, S Lines, AJP Lewington, Acute kidney injury in the critically ill patient, Current Anaesthesia & Critical Care 21 (2), 60-64, April 2010
  • Seerapani Gopaluni, Aadil Shaukat, Martin Gray, Roshni Gokhale and M Al-Bustami Premature myocardial infarction presenting with acuacutete pulmonary embolism: a case report. Journal of Medical Case Reports 2009, 3:8786